Plasma levels of endothelial and B-cell-derived microparticles are restored by fingolimod treatment in multiple sclerosis patients

Conclusion:
Fingolimod restored dysregulated endothelial and B-cell-microparticle numbers, which could serve as a biomarker in MS.

Source: Multiple Sclerosis - December 8, 2016 Category: Neurology Authors: Zinger, A., Latham, S. L., Combes, V., Byrne, S., Barnett, M. H., Hawke, S., Grau, G. E. Tags: Short Report Source Type: research